COVID-19.рф: ИНФОРМАЦИЯ ПРОТИВ ПАНДЕМИИ

Поиск по репозиторию

Статья

A new threat from an old enemy: Re-emergence of coronavirus (Review)

A. Docea, A. Tsatsakis, D. Albulescu, O. Cristea, O. Zlatian, M. Vinceti, S. Moschos, D. Tsoukalas, M. Goumenou, N. Drakoulis, J. Dumanov1, V. Tutelyan, G. Onischenko, M. Aschner, D. Spandidos, D. Calina,
2021
https://doi.org/10.3892/ijmm.2020.4555

The new outbreak of coronavirus from December 2019 has brought attention to an old viral enemy and has raised concerns as to the ability of current protection measures and the healthcare system to handle such a threat. It has been known since the 1960s that coronaviruses can cause respiratory infections in humans; however, their epidemic potential was understood only during the past two decades. © 2020 Spandidos Publications. All rights reserved.

Цитирование

Похожие публикации

Tobacco smoking and COVID-19: An old enemy in a new guise. Review of current publications
M. Gambaryan, O. Drapkina,
Концепция возникновения новой коронавирусной инфекции
Дорофейчук В. Г., Шер С. А.,
An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare
D. Gorenkov, L. Khantimirova, V. Shevtsov,

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • A. Docea
    Department of Toxicology, University of Medicine and Pharmacy of Craiova, 2 Petru Rares Street, Craiova, 200349, Romania
  • A. Tsatsakis
    Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, Heraklion, 71003, Greece
  • D. Albulescu
    Russian Academy of Sciences, Moscow, 119991, Russian Federation
  • O. Cristea
    State Education Institution of Higher Professional Training, First Sechenov Moscow State Medical University under Ministry of Health of the Russian Federation, Moscow, 119992, Russian Federation
  • O. Zlatian
    Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY 10461, United States
  • M. Vinceti
    Departments of Radiology, University of Medicine and Pharmacy of Craiova, Craiova, 200349, Romania
  • S. Moschos
    Departments of Microbiology, University of Medicine and Pharmacy of Craiova, Craiova, 200349, Romania
  • D. Tsoukalas
    Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, I-41125, Italy
  • M. Goumenou
    Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, United States
  • N. Drakoulis
    Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, United Kingdom
  • J. Dumanov1
    PulmoBioMed Ltd., Newcastle-Upon-Tyne, NE1 8ST, United Kingdom
  • V. Tutelyan
    Metabolomic Medicine, Health Clinics for Autoimmune and Chronic Diseases, Athens, 10674, Greece
  • G. Onischenko
    Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, 15771, Greece
  • M. Aschner
    Mycological Institute US EU, Subclinical Research Group, Sparta, NJ 07871, United States
  • D. Spandidos
    Federal Research Centre of Nutrition and Biotechnology, Moscow, 109240, Russian Federation
  • D. Calina
    Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion, 71003, Greece
Название журнала
  • International Journal of Molecular Medicine
Том
  • 45
Выпуск
  • 6
Страницы
  • 1631-1643
Ключевые слова
  • 2,4 thiazolidinedione derivative; angiotensin converting enzyme 2; angiotensin receptor antagonist; antifungal agent; antihypertensive agent; antiinfective agent; chloroquine; colecalciferol; consensus interferon; corticosteroid; dipeptidyl carboxypeptidase inhibitor; Human immunodeficiency virus proteinase inhibitor; ibuprofen; immunoglobulin; lopinavir; lopinavir plus ritonavir; mycophenolic acid; remdesivir; ribavirin; ritonavir; sarilumab; severe acute respiratory syndrome vaccine; tocilizumab; virus spike protein; adult respiratory distress syndrome; age distribution; artificial ventilation; case fatality rate; computer assisted tomography; contact examination; coronavirus disease 2019; Coronavirus infection; diabetes mellitus; disease re-emergence; epidemic; flu like syndrome; fomite; genetic similarity; ground glass opacity; human; hypertension; intensive care; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; nonhuman; nose smear; point of care testing; prevalence; priority journal; real time polymerase chain reaction; respiratory tract parameters; Review; SARS coronavirus; SARS-related coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; vertical transmission; virion; virus entry; virus genome; virus infectivity; virus load; virus pathogenesis; virus pneumonia; virus replication; virus transmission; virus virulence; Betacoronavirus; Coronavirinae; Coronavirus infection; epidemic; pandemic; pathogenicity; physiology; virology; virus pneumonia; Betacoronavirus; Coronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Pandemics; Pneumonia, Viral
Издатель
  • Spandidos Publications
Тип документа
  • Review
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus
COVID-19.рф: Информация против пандемии

Адрес: 115114, Москва, ул. Летниковская, д. 4, стр.5, офис 2.4
тел.\факс: +7(499)754-99-94, доб. 502
e-mail: covid19@neicon.ru

Проект реализуется с использованием гранта Президента Российской Федерации на развитие гражданского общества, предоставленного Фондом президентских грантов.

Содержимое сайта, если не указано иное, опубликовано в соответствии с лицензией Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная (CC BY 4.0). Права на материалы, переданные партнерами проекта, принадлежат их правообладателям.

© 2025 NEICON